Previous studies have shown that NLRP3 deficiency is associated with a significantly increased incidence of colitis and colorectal cancer induced by the DNA-damaging agent azomethane (AOM) and the chemical colitogenic dextran sulfate sodium (DSS) in mouse models [40,41]. The gene discussed is NLRP3; the disease is colitis.